期刊文献+

2型糖尿病患者血清IGF-1水平与颈动脉粥样斑块的相关性研究 被引量:4

The Relationship between Serum IGF-1 and carotid atheromatous plaque in T2DM patients
下载PDF
导出
摘要 目的探讨2型糖尿病(T2DM)患者血清胰岛素样生长因子-1(IGF-1)水平与双侧颈动脉粥样硬化斑块的相关性。方法应用超声检测186例患者双侧颈动脉内膜-中膜厚度,根据超声检查结果将其分为:(1)A组(颈动脉粥样硬化斑块阳性的T2DM患者)96例;(2)B组(颈动脉粥样硬化斑块阴性的T2DM患者)90例。并采用免疫放射分析法检测两组患者的血清IGF-1水平。结果 A组患者的血清IGF-1水平与B组比较显著降低,差异有显著统计学意义(P<0.01);T2DM患者血清IGF-1水平与双侧颈动脉粥样斑块的程度呈显著负相关(r=0.649,P<0.01)。结论 IGF-1参与了T2DM大血管病变的发生、发展,IGF-1水平与颈动脉粥样斑块程度密切相关。 Objective To observe between serum IGF-1 levels and carotid atheromatous plaque in T2DM patients.Methods 186 T2DM patients were measured with their bilateral carotid intima media thickness(IMT).According to the result of ultrasonic examination,patients were divided into plaque group (n =96) and no plaque group (n =90).Plasma IGF-1 levels were measured by Immunoradiometric assay.Results IGF-1 levels were lower in plaque group than in no plaque group (P < 0.01).IGF-1 levels were negative correlation with the degree of carotid atheromatous plaque(r =0.649,P < 0.01).Conclusion IGF-1 may be involved in the occurrence and development of macroangiopathy in T2DM.
机构地区 解放军第
出处 《临床军医杂志》 CAS 2015年第4期366-368,共3页 Clinical Journal of Medical Officers
关键词 2型糖尿病 血清胰岛素样生长因子-1 颈动脉粥样硬化斑块 Type 2 diabetes mellitus serum insulin-like growth factor-1 carotid atheromatous plaque
  • 相关文献

参考文献12

  • 1Goraya TY, Leibson CL, Palumbo PJ, et al. Coronary athero- sclerosis in diabetes me|litus: a population based autopsy study [ J ]. J Am Coil Cardiol,2002,40 (5) :946 - 953.
  • 2Kahn CR, Weir GC, King GL, et al. Joslin' s Diabetes Mellitus [J]. 14th edition. Philadelphia: Lea and Febiger, 2005,477 -492.
  • 3Raipathak SN, Gunter M J, Wylie-R J, et al. The role of insulin- like growth factor-1 and its binding proteins in glucose homeo- stasis and type 2 diabetes [J].Diabetes/Metabolism Research and Reviews,2009, 25 ( 1 ) :3 - 12.
  • 4Kallikazaros I,Tsioufis C,Sideris S, et al. Carotid artery disease as a maker for the presence of severe coronary artery disease in patients evaluate for chest pain[ J ]. Stroke, 1999,30 (5) :1002 - 1007.
  • 5Rincon M, Rudin E, Barzilai N. The insulin/IGF-1 signaling in mammals and its relevance to human longevity [ J ]. Exp Geron- tol,2005,40( 11 ) :873 - 877.
  • 6Janssen JA, Lamberts SW. The role of IGF-1 in the devlopment of cardiovascular diabetic in type 2 diabetes mellitus:is preven- tion possible [ J ] ? Eur J Endocrinol, 2002, 146 ( 4 ) : 467 - 477.
  • 7Colao A,Spiezia S, Di Somma C,et al. Circulating insulin-like growth factor-1 levels are correlated with the atherosclerotic pro- file in healthy subjects independently of age [ J ]. J Endocrinol Invest, 2005,28 ( 5 ) :440 - 448.
  • 8Clemmons DR. Role of insulin-like growth factor I in maintai- ning normal glucose homeostasis[ J]. Horm Res, 2004,62 : 77 - 82.
  • 9Moses AC. Insulin resistance and type 2 diabetes mellitus: is there a therapeutic role for IGF-1 [ J] ? Endocr Dev, 2005, 9 : 121- 134.
  • 10Standley PR,Zhang F, Iayas RM, et al. IGF-I regulation of Na ( + ). K( + ). ATPase in rat arterial smooth muscle[J]. Am J Physiol,1997, 273 : 113 - 121.

同被引文献50

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部